Feasibility, safety and tolerability of accelerated dobutamine stress echocardiography
2007

Accelerated Dobutamine Stress Echocardiography Study

Sample size: 265 publication Evidence: moderate

Author Information

Author(s): Minardi Giovanni, Manzara Carla, Pulignano Giovanni, Pino Paolo G, Pavaci Herribert, Sordi Martina

Primary Institution: Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy

Hypothesis

Is an accelerated dobutamine stress protocol feasible, safe, and tolerable for patients with suspected or known coronary artery disease?

Conclusion

The study demonstrates that a continuous infusion of a single high dose of dobutamine is a safe and well-tolerated method for performing stress echocardiography in patients with suspected or known coronary artery disease.

Supporting Evidence

  • The mean weight-adjusted cumulative dose of dobutamine used was 330 ± 105.24 μg/kg.
  • Total duration of dobutamine infusion was 6.6 ± 2.1 min.
  • Heart rate rose from 69.9 ± 12.1 to 123.1 ± 22.1 beats/min at peak.
  • No major side effects were observed during the test.
  • The test resulted positive in 61 patients due to new or worsening wall motion abnormalities.

Takeaway

Doctors tested a new way to use dobutamine for heart stress tests, and it worked well without causing major problems.

Methodology

265 consecutive patients underwent accelerated dobutamine stress echocardiography with dobutamine administered at a constant dose of 50 μg/kg/min for up to 10 minutes.

Limitations

The study represents a single center experience and requires a larger sample size for better evaluation of uncommon side effects.

Participant Demographics

{"mean_age":63.3,"male_percentage":69.8,"hypertension_percentage":53.6,"diabetes_percentage":19.2,"dyslipidemia_percentage":43.8,"smoking_percentage":20.4}

Digital Object Identifier (DOI)

10.1186/1476-7120-5-40

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication